Gallagher Patrick Stephen has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 9383 shares of Sensei Biotherapeutics, Inc. ($SNSE) on February 15, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | F | Common Stock | 9383 | $1.50 | 34,130.0000 | 0 | 21.56% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 29313 | $0.00 | 29,313.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 14200 | $0.00 | 43,513.0000 | 0 | 48.44% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 29313 | $0.00 | 29,313.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Common Stock | 14200 | $0.00 | 43,515.0000 | 0 | 48.44% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Gallagher Patrick Stephen | Chief Business Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |